317 related articles for article (PubMed ID: 29520280)
1. The Influence of Invariant Natural Killer T Cells on Humoral Immunity to T-Dependent and -Independent Antigens.
Lang ML
Front Immunol; 2018; 9():305. PubMed ID: 29520280
[TBL] [Abstract][Full Text] [Related]
2. Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B.
Rampuria P; Lang GA; Devera TS; Gilmore C; Ballard JD; Lang ML
J Leukoc Biol; 2017 Feb; 101(2):567-576. PubMed ID: 27566831
[TBL] [Abstract][Full Text] [Related]
3. Immunization-Expanded NKT Follicular Helper Cells Drive IgG1 Isotype Switch against an Exogenous T-Independent Polysaccharide but Do Not Promote Recall Responses.
Lang GA; Amadou Amani S; Quinn JL; Axtell RC; Lang ML
Immunohorizons; 2019 Mar; 3(3):88-93. PubMed ID: 31342012
[TBL] [Abstract][Full Text] [Related]
4. The importance of B cell CD1d expression for humoral immunity.
Lang ML
Expert Rev Vaccines; 2014 Nov; 13(11):1275-8. PubMed ID: 24946838
[TBL] [Abstract][Full Text] [Related]
5. Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses.
Fujii SI; Yamasaki S; Sato Y; Shimizu K
Front Immunol; 2018; 9():1267. PubMed ID: 29915600
[TBL] [Abstract][Full Text] [Related]
6. CD40L-null NKT cells provide B cell help for specific antibody responses.
Shah HB; Joshi SK; Lang ML
Vaccine; 2011 Nov; 29(49):9132-6. PubMed ID: 21959330
[TBL] [Abstract][Full Text] [Related]
7. Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory.
Lang GA; Johnson AM; Devera TS; Joshi SK; Lang ML
Int Immunol; 2011 Apr; 23(4):251-60. PubMed ID: 21398691
[TBL] [Abstract][Full Text] [Related]
8. Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides.
Bai L; Deng S; Reboulet R; Mathew R; Teyton L; Savage PB; Bendelac A
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16097-102. PubMed ID: 24043771
[TBL] [Abstract][Full Text] [Related]
9. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
Lang GA; Exley MA; Lang ML
Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
[TBL] [Abstract][Full Text] [Related]
10. Interview: glycolipid antigen presentation by CD1d and the therapeutic potential of NKT cell activation.
Kronenberg M
J Vis Exp; 2007; (10):635. PubMed ID: 18989407
[TBL] [Abstract][Full Text] [Related]
11. Glycolipid activators of invariant NKT cells as vaccine adjuvants.
Kharkwal SS; Arora P; Porcelli SA
Immunogenetics; 2016 Aug; 68(8):597-610. PubMed ID: 27377623
[TBL] [Abstract][Full Text] [Related]
12. How do natural killer T cells help B cells?
Lang ML
Expert Rev Vaccines; 2009 Aug; 8(8):1109-21. PubMed ID: 19627191
[TBL] [Abstract][Full Text] [Related]
13. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
[TBL] [Abstract][Full Text] [Related]
14. NKT cell responses to glycolipid activation.
Tefit JN; Davies G; Serra V
Methods Mol Biol; 2010; 626():149-67. PubMed ID: 20099127
[TBL] [Abstract][Full Text] [Related]
15. Analyzing Antigen Recognition by Natural Killer T Cells.
Zeissig S; Blumberg RS
Methods Mol Biol; 2019; 1988():439-453. PubMed ID: 31147957
[TBL] [Abstract][Full Text] [Related]
16. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.
Venkataswamy MM; Porcelli SA
Semin Immunol; 2010 Apr; 22(2):68-78. PubMed ID: 19945296
[TBL] [Abstract][Full Text] [Related]
17. Memory Follicular Helper Invariant NKT Cells Recognize Lipid Antigens on Memory B Cells and Elicit Antibody Recall Responses.
Chen Z; Zhu S; Wang L; Xie D; Zhang H; Li X; Zheng X; Du Z; Li J; Bai L
J Immunol; 2018 May; 200(9):3117-3127. PubMed ID: 29581354
[TBL] [Abstract][Full Text] [Related]
18. Optimizing NKT cell ligands as vaccine adjuvants.
Carreño LJ; Kharkwal SS; Porcelli SA
Immunotherapy; 2014; 6(3):309-20. PubMed ID: 24762075
[TBL] [Abstract][Full Text] [Related]
19. Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.
Joshi SK; Lang GA; Devera TS; Johnson AM; Kovats S; Lang ML
J Leukoc Biol; 2012 May; 91(5):783-90. PubMed ID: 22331103
[TBL] [Abstract][Full Text] [Related]
20. CD1d-dependent expansion of NKT follicular helper cells in vivo and in vitro is a product of cellular proliferation and differentiation.
Rampuria P; Lang ML
Int Immunol; 2015 May; 27(5):253-63. PubMed ID: 25710490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
